Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky Sells 16,752 Shares

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 16,752 shares of the stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $63.21, for a total transaction of $1,058,893.92. Following the completion of the transaction, the chief executive officer now owns 4,878,837 shares in the company, valued at $308,391,286.77. This represents a 0.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Tempus AI Stock Up 1.9%

NASDAQ:TEM opened at $59.25 on Friday. The stock has a 50-day simple moving average of $51.22 and a 200 day simple moving average of $52.07. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $91.45. The company has a market cap of $10.20 billion and a PE ratio of -7.60. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.03. The firm had revenue of $255.74 million for the quarter, compared to analyst estimates of $248.13 million. The firm’s quarterly revenue was up 75.4% on a year-over-year basis. On average, sell-side analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on TEM shares. Wolfe Research lowered Tempus AI from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Guggenheim restated a “buy” rating on shares of Tempus AI in a report on Tuesday, February 25th. Piper Sandler increased their target price on shares of Tempus AI from $55.00 to $70.00 and gave the stock a “neutral” rating in a report on Thursday, May 15th. William Blair reissued a “market perform” rating on shares of Tempus AI in a research report on Tuesday, February 25th. Finally, BTIG Research started coverage on shares of Tempus AI in a research report on Monday, April 21st. They issued a “buy” rating and a $60.00 price objective for the company. Six research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $63.42.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in TEM. Victory Capital Management Inc. bought a new stake in Tempus AI during the 4th quarter worth about $216,000. China Universal Asset Management Co. Ltd. acquired a new stake in shares of Tempus AI in the fourth quarter valued at about $1,091,000. Wells Fargo & Company MN raised its holdings in Tempus AI by 13.2% during the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company’s stock worth $80,000 after acquiring an additional 278 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new stake in Tempus AI during the fourth quarter worth about $178,000. Finally, abrdn plc acquired a new position in Tempus AI during the fourth quarter valued at approximately $2,784,000. Institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.